320 related articles for article (PubMed ID: 9657561)
81. Changes in sputum eosinophils predict loss of asthma control.
Jatakanon A; Lim S; Barnes PJ
Am J Respir Crit Care Med; 2000 Jan; 161(1):64-72. PubMed ID: 10619799
[TBL] [Abstract][Full Text] [Related]
82. Neutrophilic inflammation in severe persistent asthma.
Jatakanon A; Uasuf C; Maziak W; Lim S; Chung KF; Barnes PJ
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1532-9. PubMed ID: 10556116
[TBL] [Abstract][Full Text] [Related]
83. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma.
Niimi A; Amitani R; Suzuki K; Tanaka E; Murayama T; Kuze F
Clin Exp Allergy; 1998 Feb; 28(2):233-40. PubMed ID: 9515598
[TBL] [Abstract][Full Text] [Related]
84. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
[TBL] [Abstract][Full Text] [Related]
85. Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma.
Scichilone N; Battaglia S; Sorino C; Paglino G; Martino L; Paternò A; Santagata R; Spatafora M; Nicolini G; Bellia V
Allergy; 2010 Jul; 65(7):897-902. PubMed ID: 20121764
[TBL] [Abstract][Full Text] [Related]
86. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma.
Ukena D; Harnest U; Sakalauskas R; Magyar P; Vetter N; Steffen H; Leichtl S; Rathgeb F; Keller A; Steinijans VW
Eur Respir J; 1997 Dec; 10(12):2754-60. PubMed ID: 9493656
[TBL] [Abstract][Full Text] [Related]
87. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
Busse WW; Brazinsky S; Jacobson K; Stricker W; Schmitt K; Vanden Burgt J; Donnell D; Hannon S; Colice GL
J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
[TBL] [Abstract][Full Text] [Related]
88. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
Simons FE
N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
[TBL] [Abstract][Full Text] [Related]
89. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma.
Hoshino M; Nakamura Y; Sim JJ; Yamashiro Y; Uchida K; Hosaka K; Isogai S
Clin Exp Allergy; 1998 May; 28(5):568-77. PubMed ID: 9645593
[TBL] [Abstract][Full Text] [Related]
90. Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children.
La Grutta S; Nicolini G; Capristo C; Bellodi SC; Rossi GA
Monaldi Arch Chest Dis; 2007 Mar; 67(1):30-8. PubMed ID: 17564282
[TBL] [Abstract][Full Text] [Related]
91. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
[TBL] [Abstract][Full Text] [Related]
92. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults.
Aziz I; Wilson AM; Lipworth BJ
Chest; 2000 Oct; 118(4):1049-58. PubMed ID: 11035676
[TBL] [Abstract][Full Text] [Related]
93. Bronchial asthma showing reduction in FEV1 after inhalation of Qvar.
Nobata K; Fujimura M; Myou S; Ishiura Y; Mizuguchi M; Nishi K; Nakao S
J Asthma; 2006 Aug; 43(6):427-8. PubMed ID: 16952859
[TBL] [Abstract][Full Text] [Related]
94. Airway response to formaldehyde inhalation in asthmatic subjects with suspected respiratory formaldehyde sensitization.
Krakowiak A; Górski P; Pazdrak K; Ruta U
Am J Ind Med; 1998 Mar; 33(3):274-81. PubMed ID: 9481426
[TBL] [Abstract][Full Text] [Related]
95. Do sputum eosinophils and ECP relate to the severity of asthma?
Ronchi MC; Piragino C; Rosi E; Stendardi L; Tanini A; Galli G; Duranti R; Scano G
Eur Respir J; 1997 Aug; 10(8):1809-13. PubMed ID: 9272923
[TBL] [Abstract][Full Text] [Related]
96. HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study.
Kobayashi Y; Yasuba H; Asako M; Yamamoto T; Takano H; Tomoda K; Kanda A; Iwai H
Front Immunol; 2018; 9():2192. PubMed ID: 30337921
[No Abstract] [Full Text] [Related]
97. Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients.
Inoue H; Aizawa H; Fukuyama S; Takata S; Matsumoto K; Shigyo M; Koto H; Hara N
Lung; 1999; 177(1):53-62. PubMed ID: 9835634
[TBL] [Abstract][Full Text] [Related]
98. Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children.
Sorva R; Metso T; Turpeinen M; Juntunen-Backman K; Björksten F; Haahtela T
Pediatr Allergy Immunol; 1997 Feb; 8(1):45-50. PubMed ID: 9260219
[TBL] [Abstract][Full Text] [Related]
99. Effects of theophylline withdrawal in well-controlled asthmatics treated with inhaled corticosteroid.
Baba K; Sakakibara A; Yagi T; Niwa S; Hattori T; Koishikawa I; Yoshida K; Kobayashi T; Takagi K
J Asthma; 2001 Dec; 38(8):615-24. PubMed ID: 11758890
[TBL] [Abstract][Full Text] [Related]
100. Serum eosinophil cationic protein for predicting the prognosis of a step-down in inhaled corticosteroid therapy in adult chronic asthmatics.
Baba K; Hattori T; Koishikawa I; Yoshida K; Kobayashi T; Takagi K
J Asthma; 2000 Aug; 37(5):399-408. PubMed ID: 10983617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
